Zobrazeno 1 - 10
of 61
pro vyhledávání: '"M. Gisslen"'
Publikováno v:
Journal of Virus Eradication, Vol 1, Iss , Pp 33- (2015)
Externí odkaz:
https://doaj.org/article/2c27f168fc714585a6fc75c4dd39724a
Autor:
I A Hawes, B D Alvarenga, W Browne, A Wapniarski, R Dandekar, C M Bartley, G M Sowa, J L Derisi, P Cinque, S J Pleasure, M Gisslen, R W Price, M R Wilson, M A S †, Ameet Dravid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::550607a000997d16284a8715c7cf0e81
Autor:
I.A. Hawes, B.D. Alvarenga, W. Browne, A. Wapniarski, R. Dandekar, C.M. Bartley, G.M. Sowa, J.L. DeRisi, P. Cinque, A.N. Dravid, S.J. Pleasure, M. Gisslen, R.W. Price, M.R. Wilson
BackgroundAntiretroviral therapy (ART) suppresses plasma and cerebrospinal fluid (CSF) HIV replication with occasional asymptomatic episodes of detectable HIV RNA known as asymptomatic (AS) escape. Neurosymptomatic (NS) CSF escape is a rare exception
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ae5aaa8ccb57a880457a1b86f5f1b6b
https://doi.org/10.1101/2022.12.13.22283439
https://doi.org/10.1101/2022.12.13.22283439
Autor:
Jan Vesterbacka, Piotr Nowak, Anders Sönnerborg, Babilonia Barqasho, H Funaoka, T Kanda, M Gisslen
Publikováno v:
Journal of the International AIDS Society. 15
Intestinal fatty acid binding protein (I-FABP) was proposed as a plasma marker of enterocyte turnover that could be applied to estimate the level of gut damage in HIV-1 infected patients. We investigated the kinetics of I-FABP in patients starting an
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461380269
A high percentage of patients with human immunodeficiency virus infection presents with decreased tryptophan concentrations in serum and cerebrospinal fluid. In parallel degradation products of tryptophan like kynurenine and quinolinic acid are incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fea348d4ca599a8fa272c2c69c09f84
https://doi.org/10.1007/978-1-4613-0381-7_21
https://doi.org/10.1007/978-1-4613-0381-7_21
Autor:
Li X; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Edén A; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41685, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Disease, Gothenburg, 41685, Sweden., Malwade S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Cunningham JL; Department of Medical Science, Psychiatry, Uppsala University, Uppsala 75185, Sweden; Department of Neuroscience, Karolinska Institute, Stockholm 17177, Sweden., Bergquist J; Analytical Chemistry and Neurochemistry, Department of Chemistry─BMC, Uppsala University, Box 599, 751 24 Uppsala, Sweden; The ME/CFS Collaborative Research Centre at Uppsala University, 751 24 Uppsala, Sweden., Weidenfors JA; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Sellgren CM; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden., Engberg G; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden; Institute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania., Piehl F; Unit of Neuroimmunology, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm 17177, Sweden; Division of Neurology, Karolinska University Hospital, Stockholm 17176, Sweden., Gisslen M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41685, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Disease, Gothenburg, 41685, Sweden; Public Health Agency of Sweden, Solna, Sweden., Kumlien E; Department of Medical Sciences, Neurology, Uppsala University, Uppsala 75185, Sweden., Virhammar J; Department of Medical Sciences, Neurology, Uppsala University, Uppsala 75185, Sweden., Orhan F; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Rostami E; Department of Neuroscience, Karolinska Institute, Stockholm 17177, Sweden; Department of Medical Sciences, Neurology, Uppsala University, Uppsala 75185, Sweden., Schwieler L; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Erhardt S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: sophie.erhardt@ki.se.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2024 Nov 28. Date of Electronic Publication: 2024 Nov 28.
Autor:
Kincer LP; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Dravid A; Department of Medicine, Poona Hospital and Research Center, Pune, India.; Ruby Hall Clinic, Pune, India., Trunfio M; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin at the 'Amedeo di Savoia' Hospital, Torino, Italy., Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin at the 'Amedeo di Savoia' Hospital, Torino, Italy.; ASL 'CIttà di Torino,' Torino, Italy., Zhou S; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Vercesi R; Unit of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy., Spudich S; Department of Neurology, Yale University, New Haven, Connecticut, USA., Gisslen M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; Public Health Agency of Sweden, Solna, Sweden., Price RW; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Cinque P; Unit of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy., Joseph SB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Microbiology and Immunology and.; UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Oct 01; Vol. 134 (19). Date of Electronic Publication: 2024 Oct 01.
Autor:
Catalano AA; Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA., Yoon J; Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA., Fertuzinhos S; Bioinformatics Support Hub, Cushing/Whitney Library, Yale School of Medicine, New Haven, CT, USA., Reisert H; Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA., Walsh H; Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA., Kosana P; Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA., Wilson M; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Gisslen M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Marra CM; Department of Neurology, University of Washington School of Medicine, Seattle, WA, USA., Farhadian SF; Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA; Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA. Electronic address: shelli.farhadian@yale.edu.
Publikováno v:
Med (New York, N.Y.) [Med] 2024 Apr 12; Vol. 5 (4), pp. 321-334.e3. Date of Electronic Publication: 2024 Mar 20.
Autor:
Fredolini C; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden.; Affinity Proteomics Unit, SciLifeLab Infrastructure, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Dodig-Crnković T; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Bendes A; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Dahl L; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Dale M; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden.; Affinity Proteomics Unit, SciLifeLab Infrastructure, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Albrecht V; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Mattsson C; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden.; Affinity Proteomics Unit, SciLifeLab Infrastructure, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Thomas CE; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden., Torinsson Naluai Å; Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, 405 30, Gothenburg, Sweden., Gisslen M; Department of Infectious Diseases, The Sahlgrenska Academy at University of Gothenburg, 405 30, Gothenburg, Sweden.; Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden.; Public Health Agency of Sweden, 171 65, Solna, Sweden., Beck O; Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden., Roxhed N; MedTechLabs, BioClinicum, Karolinska University Hospital, 171 64, Solna, Sweden. roxhed@kth.se.; Department of Micro and Nanosystems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology Stockholm, 100 44, Stockholm, Sweden. roxhed@kth.se., Schwenk JM; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, 171 65, Solna, Sweden. jochen.schwenk@scilifelab.se.
Publikováno v:
Communications medicine [Commun Med (Lond)] 2024 Apr 02; Vol. 4 (1), pp. 55. Date of Electronic Publication: 2024 Apr 02.
Autor:
Hawes IA; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA; University of California San Francisco, Biomedical Sciences Graduate Program, CA, USA; University of California San Francisco, School of Medicine, CA, USA., Alvarenga BD; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA., Browne W; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA., Wapniarski A; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA., Dandekar R; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA., Bartley CM; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, CA, USA., Sowa GM; University of California San Francisco, School of Medicine, CA, USA; Department of Medicine, Northwestern University, Chicago, IL, United States of America., DeRisi JL; Chan Zuckerberg Biohub, San Francisco, CA, USA; Department of Biochemistry and Biophysics, University of California San Francisco, CA, USA., Cinque P; Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy., Dravid AN; Poona Hospital and Research Centre and Noble Hospital, Pune, India., Pleasure SJ; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA., Gisslen M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Price RW; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA., Wilson MR; Weill Institute for Neurosciences, University of California San Francisco, CA, USA; Department of Neurology, University of California San Francisco, CA, USA. Electronic address: michael.wilson@ucsf.edu.
Publikováno v:
Journal of neuroimmunology [J Neuroimmunol] 2023 Aug 15; Vol. 381, pp. 578141. Date of Electronic Publication: 2023 Jun 28.